U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QSB  x
        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the quarterly period ended April 30, 2006  o
        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the transition period from  Commission File No. 000-50814  MEDARTS MEDICAL SYSTEM, INC. (Exact name of small business issuer as specified in its charter)  Delaware(State or other jurisdiction of incorporationor organization)
        (I.R.S. Employer Identification No.)  6/F E  Yang International Mansion #27 Science & Technology Road Xi- an Hi- Tech Industry Development Zone Xi an PRC 710075 (Address of principal executive offices )(Zip Code)  86-29-88319908 (Registrants telephone no., including area code)  (Former name, address and fiscal year, if changed since last report)  Check whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the issuer was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YesxNoo  Indicate by check mark whether the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act. Yes
        x
        No
        o  State the number of shares outstanding of each of the issuers classes of common equity, as of April 30, 2006: 100,000 shares of common stock.      TABLE OF CONTENTS




PART I  FINANCIAL INFORMATIONItem 1.  Financial Information
        1Item 2.  Managements Discussion and Analysis or Plan of Operation
        10Item 3.  Controls and Procedures
        11PART II -OTHER INFORMATIONItem 1.  Legal Proceedings.
        12Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.
        12Item 3.  Defaults Upon Senior Securities.
        12Item 4.  Submission of Matters to a Vote of Security Holders.
        12Item 5.  Other Information.
        12Item 6.  Exhibits and Reports of Form 8-K.
        12SIGNATURES




i



PART I  FINANCIAL INFORMATION




Item 1.
        Financial Information





Medarts Medical System, Inc.(Formerly, Unise Investment Holdings of China, Inc. and Along Mobile Technology, Inc.)(A Development Stage Company)Balance SheetApril 30, 2006(Unaudited)AssetsCurrent assets:Cash and cash equivalents
        
        
        $
        -Total  current assets
        
        
        $
        -Liabilities and Stockholders DeficitCurrent liabilitiesAccounts payable and accrued expenses
        
        
        $
        3,615Total current liabilities
        
        
        
        3,615Stockholders deficitCommon stock, $.0001 par value; 100,000,000 sharesauthorized, 100,000 shares issued and outstanding
        
        
        10Additional paid-in capital
        
        
        
        90Deficit accumulated during the development stage
        
        
        (3,715)Total stockholders deficit
        
        
        
        (3,615)Total liabilities and stockholders deficit
        
        $
        -The accompanying notes form an integral part of these unaudited financial statements


1

Medarts Medical System, Inc.(Formerly, Unise Investment Holdings of China, Inc. and Along Mobile Technology, Inc.)(A Development Stage Company)Statements of Operations(Unaudited)CumulativeDuring theDevelopmentThree Month Periods Ended
        
        Six Month Periods Ended
        
        StageApril 30
        
        April 30
        
        (August 19, 2004 to2006
        
        2005
        
        2006
        
        2005
        
        April 30, 2006)Net revenues
        $
        -
        $
        -
        $
        -
        $
        -
        $
        -General and administrative expense
        
        1,500
        
        -
        
        1,765
        
        1,350
        
        3,715Total expenses
        
        1,500
        
        -
        
        1,765
        
        1,350
        
        3,715Net loss
        $
        (1,500)
        $
        -
        $
        (1,765)
        $
        (1,350)
        $
        (3,715)Net loss per share,basic and diluted
        $
        (0.02)
        $
        -
        $
        (0.02)
        $
        (0.01)
        $
        -Weighted average number of commonShares outstanding,basic and diluted
        
        100,000
        
        100,000
        
        100,000
        
        100,000
        
        100,000The accompanying notes form an integral part of these unaudited financial statements
2




Medarts Medical System, Inc.(Formerly, Unise Investment Holdings of China, Inc. and Along Mobile Technology, Inc.)(A Development Stage Company)Statements of Statement of stockholders Deficit(Unaudited)From inception(August 19,2004) trough April 30,2006Additional
        
        
        
        TotalCommon Stock
        paid in
        
        Accumulated
        StockholdersShares
        
        Amount
        Capital
        
        Deficit
        
        DeficitStock issued on acceptanceof incorporation expenses
        100,000
        $
        10
        $
        90
        $
        -
        $
        100Net Loss
        
        -
        
        -
        
        -
        
        (600)
        
        (600)Total at October 31, 2004
        100,000
        
        10
        
        90
        
        (600)
        
        (500)Net loss
        
        -
        
        -
        
        -
        
        (1,350)
        
        (1,350)Total at October 30,2005
        100,000
        
        10
        
        90
        
        (1,950)
        
        (1,850)Net loss
        
        -
        
        -
        
        -
        
        (1,765)
        
        (1,765)Total at April 30, 2006
        100,000
        $
        10
        $
        90
        $
        (3,715)
        $
        (3,615)The accompanying notes form an integral part of these unaudited financial statements
3


Medarts Medical System ,Inc.(Formerly, Unise Investment Holdings of China, Inc. and Along Mobile Technology, Inc.)(A Development Stage Company)Statements of Cash Flows(Unaudited)CumulativeSix Month Periods Ended
        
        
        StageApril 30,
        
        
        (August 19,2004to2006
        
        
        2005
        
        
        April 30,2006Cash flows from operating activitiesNet loss
        $
        (1,765)
        
        $
        (1,350)
        
        $
        (3,715)Adjustments to reconcile net loss to net cashused in operating activities:Services rendered for common stock
        
        -
        
        
        -
        
        
        100Changes in operating assets and liabilities:Accounts payable and accrued expenses
        1,765
        
        
        1,350
        
        
        3,715Net cash provied by (used in ) operating activities
        -
        
        
        -
        
        
        -Cash folws from investing activities
        
        -
        
        
        -
        
        
        -Cash flows from financing activities
        
        -
        
        
        -
        
        
        -Net increase(decrease )in cash
        
        -
        
        
        -
        
        
        -Cash and cash equivalents - beginning of period
        
        -
        
        
        -
        
        
        -Cash and cash equivalents - end of period
        $
        -
        
        $
        -
        
        $
        -Supplemental disclosures of cash flow information:Interest paid
        $
        -
        
        $
        -
        
        $
        -Income taxes paid
        $
        -
        
        $
        -
        
        $
        -The accompanying notes form an integral part of these unaudited financial statements

4


MEDARTS MEDICAL SYSTEM, INC.

(FPRMERLY,UNISE INVESTMENT HOLDINGS OF CHINA, INC.)

(A Development Stage Company)

Notes to Financial Statements

For the SIX Months Ended April 30, 2006 and

2005 and For the Period August 19, 2004 (Inception)

to April 30, 2005 (Unaudited)



NOTE 1  ORGANIZATION



Medarts Medical System, Inc. (formerly, Unise Investment Holding of China, Inc.)(the Company) was incorporated in the State of Delaware on August 19, 2004 under the name Edmonds 3, Inc. On June 29, 2005, the sole officer, director, and stockholder of the Company sold all 100,000 issued and outstanding shares of the Companys Common Stock to Shaanxi Jialong Hi-Tech Industries Inc. (Shaanxi), a corporation organized in China, for $76,000 cash. Also on June 29, 2005, the Companys name was changed from Edmonds 3, Inc. to Along Mobile Technology Inc. On June 29, 2005, the Companys intention was to merge with Shaanxi Jialong High-tech Industries, Inc., a development stage company planning to engage in the business of publishing wireless entertainment applications. Subsequently, the Company decided to seek other business entities to combine with. The combination will
likely take the form of a merger, stock for stock exchange, or stock for assets exchange.



On June 28, 2006, the Company changed its name to Medarts Medical System, Inc. The Company has no products or services; the Company is seeking a business to merge with or acquire.



NOTE 2  BASIS OF PRESENTATION



The unaudited financial statements as of April 30, 2006 and for the six  months ended April 30, 2006 and 2005 and for the period August 19, 2004 (inception) to April 30, 2006 have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with instructions to Form 10-QSB. In the opinion of management, the unaudited financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary to present fairly the financial position as of April 30, 2006 and the results of operations and cash flows for the periods ended April 30, 2006 and 2005. The financial data and other information disclosed in these notes to the interim financial statements related to these periods are unaudited. The results for the six month period ended April 30,
2006 are not necessarily indicative of the results to be expected for any subsequent quarter of the entire year ending October 31, 2006. The balance sheet at October 31, 2005 has been derived from the audited financial statements at that date.



Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to the Securities and Exchange Commissions rules and regulations. These unaudited financial statements should be read in conjunction with our audited financial statements and notes thereto for the year ended October 31, 2005 as included in our report on Form 10-KSB.


5


MEDARTS MEDICAL SYSTEM, INC.

(FPRMERLY,UNISE INVESTMENT HOLDINGS OF CHINA, INC.)

(A Development Stage Company)

Notes to Financial Statements

For the SIX Months Ended April 30, 2006 and

2005 and For the Period August 19, 2004 (Inception)

to April 30, 2005 (Unaudited)





NOTE 3  DEVELOPMENT STAGE ENTERPRISE & GOING CONCERN



The Company has been presented as a development stage enterprise in accordance with Statement of Financial Accounting Standards (SFAS) No.7, Accounting and Reporting by Development Stage Enterprises. Since inception, the Companys activities have been limited to organizational efforts and making various filings with the Securities and Exchange Commission (SEC).



GOING CONCERN



At April 30, 2006, the Company had negative working capital and a stockholders deficiency of $3,715. For the period August 19, 2004 (inception) to April 30, 2006, the Company incurred net losses of $3,715. These factors create uncertainty as to the Companys ability to continue as a going concern. The Company is making efforts to acquire a business with assets and operations. However, there is no assurance that the Company will be successful in accomplishing this objective. The financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern.



NOTE 4  SUMMARY OF SIGNIFICANT ACCOUTING POLICIES



Use of Estimates



The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.



Cash and Cash Equivalents



Cash and cash equivalents include cash in hand and cash in time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less.








6


MEDARTS MEDICAL SYSTEM, INC.

(FPRMERLY,UNISE INVESTMENT HOLDINGS OF CHINA, INC.)

(A Development Stage Company)

Notes to Financial Statements

For the SIX Months Ended April 30, 2006 and

2005 and For the Period August 19, 2004 (Inception)

to April 30, 2005 (Unaudited)





Income Taxes



The Company utilizes SFAS No. 109, Accounting for Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.



Recent Pronouncements



In February 2006, FASB issued SFAS No. 155, Accounting for Certain Hybrid Financial Instruments. SFAS No. 155 amends SFAS No 133, Accounting for Derivative Instruments and Hedging Activities, and SFAF No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities. SFAS No. 155, permits fair value remeasurement for any hybrid financial instrument that contains an embedded derivative that otherwise would require bifurcation, clarifies which interest-only strips and principal-only strips are not subject to the requirements of SFAS No. 133, establishes a requirement to evaluate interest in securitized financial assets to identify interests that are freestanding derivatives or that are hybrid financial instruments that contain an embedded derivative requiring bifurcation, clarifies that concentrations of credit risk in the form of
subordination are not embedded derivatives, and amends SFAS No. 140 to eliminate the prohibition on the qualifying special-purpose entity from holding a derivative financial instrument that pertains to a beneficial interest other than another derivative financial instrument. This statement is effective for all financial instruments acquired or issued after the beginning of the Companys first fiscal year that begins after September 15, 2006.



In March 2006 FASB issued SFAS 156 Accounting for Servicing of Financial Assets this Statement amends FASB Statement No. 140, Accounting for Transfers and Servicing of Financial Assets and Extinguishments of Liabilities, with respect to the accounting for separately recognized servicing assets and servicing liabilities. This Statement:





        Requires an entity to recognize a servicing asset or servicing liability each time it undertakes an obligation to service a financial asset by entering into a servicing contract.
        Requires all separately recognized servicing assets and servicing liabilities to be initially measured at fair value, if practicable.
        Permits an entity to choose Amortization method or  Fair value measurement method for each class of separately recognized servicing assets and servicing liabilities:



7


MEDARTS MEDICAL SYSTEM, INC.

(FPRMERLY,UNISE INVESTMENT HOLDINGS OF CHINA, INC.)

(A Development Stage Company)

Notes to Financial Statements

For the SIX Months Ended April 30, 2006 and

2005 and For the Period August 19, 2004 (Inception)

to April 30, 2005 (Unaudited)









        At its initial adoption, permits a one-time reclassification of available-for-sale securities to trading securities by entities with recognized servicing rights, without calling into question the treatment of other available-for-sale securities under Statement 115, provided that the available-for-sale securities are identified in some manner as offsetting the entitys exposure to changes in fair value of servicing assets or servicing liabilities that a servicer elects to subsequently measure at fair value.
        Requires separate presentation of servicing assets and servicing liabilities subsequently measured at fair value in the statement of financial position and additional disclosures for all separately recognized servicing assets and servicing liabilities.

This Statement is effective as of the beginning of the Companys first fiscal year that begins after September 15, 2006. Management believes that this statement will not have a significant impact on the consolidated financial statements.



NOTE 5  INCOME TAXES



No provision for income taxes has been recorded since the Company has incurred net losses since inception.



At April 30, 2006, deferred tax assets consist of:




Net operating loss carryforward
        $
        3,715Less valuation allowance
        
        (3,715)Net
        $
        -



Based on managements present assessment, the Company has not yet determined it to be more likely than not that a deferred tax asset of $753 attributable to the future utilization of the $3,715 net operating loss carryforward as of April 30, 2006 will be

realized. Accordingly, the Company has provided a 100% allowance against the deferred tax asset in the financial statements at April 30, 2006. The Company will continue to review this valuation allowance and make adjustments as appropriate. The net operating loss carryforward expires in years 2024, 2025, and 2026 in the amounts of $1,350, $265 and $1,765, respectively.



Current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs. Therefore, the amount available to offset future taxable income may be limited.


8


MEDARTS MEDICAL SYSTEM, INC.

(FPRMERLY,UNISE INVESTMENT HOLDINGS OF CHINA, INC.)

(A Development Stage Company)

Notes to Financial Statements

For the SIX Months Ended April 30, 2006 and

2005 and For the Period August 19, 2004 (Inception)

to April 30, 2005 (Unaudited)





NOTE 6  RELATED PARTY TRANSACTIONS



The Company uses the offices of Shaanxi at no cost to the Company. Shaanxi has agreed to continue this arrangement until the Company completes an acquisition or merger.



NOTE 7  SUBSEQUENT ENVENT



On June 28, 2006 the Company amended the Article of Incorporation, changing its name from Unise Investment Holdings of China, Inc. to Medarts Medical System, Inc.



On June 23, 2006 pursuant to the terms of a Stock Purchase Agreement, Unise Investment Holdings of China, Inc. purchased 100,000 shares of the Companys issued and outstanding common stock from Shaanxi Hi-Tech Medical Information Co., Ltd. The total of 100,000 shares represents all of the shares of outstanding common stock of the Company.



As part of the Acquisition and pursuant to the Stock Purchase Agreement, the following changes to the Companys directors and officers have occurred:




o
        As of June 23, 2006, the Companys President, Chief Executive Officer, Chief Technology Officer and Secretary; resigned.o
        As of June 23, 2006, new management, including the President, Chief Executive Officer, Chief Financial Officer was appointed.

NOTE 8 - RECLASSIFICATION



Certain prior period amounts have been reclassified to conform to the Six month period ended April 30, 2006 presentation.
















9



Item 2.
        Managements Discussion and Analysis or Plan of Operation

This Quarterly Report on Form 10-QSB includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), which can be identified by the use of forward-looking terminology such as, may, believe, expect, intend, anticipate, estimate or continue or the negative thereof or other variations thereon or comparable terminology. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Important factors with respect to any such forward-looking statements include, but are not limited to, the Companys limited history of operations,
the availability of additional capital necessary to execute the Companys plan of operations, the volatility of the over-the-counter bulletin board market and the effect of such volatility on the value of the marketable securities received by the Company for its services, and changes in the state and federal regulation of securities, as well as the availability of necessary personnel and general economic conditions within the United States.



Plan of Operation



The Registrant is continuing its efforts to locate a merger Candidate for the purpose of a merger. It is possible that the registrant will be successful in locating such a merger candidate and closing such merger. However, if the registrant cannot effect a non-cash acquisition, the registrant may have to raise funds from a private offering of its securities under Rule 506 of Regulation D. There is no assurance the registrant would obtain any such equity funding.



Results of Operation



The Company did not have any operating income from inception (August 19, 2004) through April 30, 2006, the registrant recognized a net loss of $3,715. Some general and administrative expenses from inception were accrued. Expenses from inception were comprised of costs mainly associated with legal, accounting and office.



Liquidity and Capital Resources



At April 30, 2006 the Company had no capital resources and will rely upon the issuance of common stock and additional capital contributions from shareholders to fund administrative expenses pending acquisition of an operating company.



Management anticipates seeking out a target company through solicitation. Such solicitation may include newspaper or magazine advertisements, mailings and other distributions to law firms, accounting firms, investment bankers, financial advisors and similar persons, the use of one or more World Wide Web sites and similar methods. No estimate can be made as to the number of persons who will be contacted or solicited. Management may engage in such solicitation directly or may employ one or more other entities to conduct or assist in such solicitation. Management and its affiliates will pay referral fees to consultants and others who refer target businesses for mergers into public companies in which management and its affiliates have an interest. Payments are made if a business combination occurs, and may consist of cash or a portion of the stock in the Company retained by management and its affiliates, or both.



The Company and or shareholders will supervise the search for target companies as potential candidates for a business combination. The Company and or shareholder may pay as their own expenses any costs incurred in supervising the search for a target company. The Company and or shareholders may enter into agreements with other consultants to assist in locating a target company and may share stock received by it or cash resulting from the sale of its securities with such other consultants.







10



Critical Accounting Policies



Our financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States (GAAP). GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenue, and expense amounts reported. These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition. We believe our use if estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or
conditions. We continue to monitor significant estimates made during the preparation of our financial statements.




Item 3.
        Controls and Procedures


(a)
        Evaluation of disclosure controls and procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), as of April 30, 2006. Based on this evaluation, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commissions rules and forms and that our disclosure and controls are designed to ensure that information required to be disclosed by us in the
reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.




(b)
        Changes in internal controls.

There were no changes (including corrective actions with regard to significant deficiencies or material weaknesses) in our internal controls over financial reporting that occurred during the first quarter ended April 30, 2006 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.







11



PART II - OTHER INFORMATION




Item 1.
        Legal Proceedings.

We are currently not a party to any pending legal proceedings and no such actions by, or to the best of our knowledge, against us have been threatened.




Item 2.
        Unregistered Sales of Equity Securities and Use of Proceeds.

None




Item 3.
        Defaults Upon Senior Securities.

None




Item 4.
        Submission of Matters to a Vote of Security Holders.

No matter was submitted during the quarter ending April 30, 2006, covered by this report to a vote of our shareholders, through the solicitation of proxies or otherwise.




Item 5.
        Other Information.

None




Item 6.
        Exhibits and Reports of Form 8-K.


(a)
        Reports on Form 8-K and Form 8K-ANone(b)
        ExhibitsExhibit Number
        Exhibit Title31.1
        Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.31.2
        Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.32.1
        Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.32.2
        Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.





12



SIGNATURES



In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, there unto duly authorized.




MEDARTS MEDICAL SYSTEM, INC.By:
        /s/ Wang JunWang Jun
Chief Executive Officer
PresidentDated:
        July 24, 2006